CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company
Quoin Pharmaceuticals Ltd.
Sign in to watch- Ticker
- QNRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 703 980 4182
- Business address
- 42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
- Former names
- Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 15,152 shares at $8.49 ($128,640)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
Page 4 of 30 · 585 filings